Health 2.0: Speaking with Dr. Scott Jenkins, CEO of Biosign
Dr. Scott Jenkins, CEO of Biosign, speaks about highlights at Health 2.0 2011 in San Francisco.
Biodesign is a medical device company whose products include "intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.